Our research looks at the basic mechanism of drug resistance in bacteria or cancer cells and then we work on translational solutions to combat these problems. Our approach felt validated at this meeting where we networked with industry end-users as well as disease-on-a chip modeling academicians.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed